Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Author Vijay Martis explains how Cipla's business model, strategy and purpose s...
The deal value comprises an upfront payment and further payments tied to the ach...
The partnership will bring together Voro Therapeutics’ tumour-activated biologic...
Two-day conference to focus on regulatory writing, AI governance, patient-centri...
Executives from both organisations, including LG AI Research head Woohyung Lim a...
The collaboration involves up to $56m in upfront payments to AbCellera for the f...
Milind Sathe analyses how public regulatory dashboards can support pharmaceutic...
As the next-generation leader of the company, Nupur Shah, CEO of Cyano Pharma is...
Company receives US FDA approval and secures 180-day generic drug exclusivity fo...
The agreement broadens AviadoBio’s existing rights, which were previously limite...
Under the deal, Simulations Plus shareholders will receive $18.50 per share, rep...
Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarificati...
Meeting discusses biotechnology strategy, AI integration, biomanufacturing and f...
Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL
This approval is said to be the first in the UK for a needle-free adrenaline tre...
The FDA granted the status to alixorexton for idiopathic hypersomnia while the E...
